DUBLIN, June 28, 2022 /PRNewswire/ — The “United States Human Vaccines Market Size, Share, In-Depth Analysis of Top 45 Human Vaccines Brands, Emerging Trends, Current Analysis, Growth, Demand, Opportunity and Forecast 2022-2028” report has been added to from ResearchAndMarkets.com offer.
Amid the COVID-19 crisis, United States the market for human vaccines is set to grow by US$31,517 million by 2028, accelerating to a CAGR 7% over the forecast period.
The main factors that are expected to contribute to the growth of United States human vaccines market:
Increased disease awareness
Approval/launch of new vaccines
Increased focus on immunization programs
Increase investment and government support for vaccine development
The report contains an in-depth analysis of United States human vaccines market size in terms of value. The report provides a clear insight into the current and future developments of United States vaccine market.
The report also explores the detailed analysis, market valuation information of Top 45 Vaccines in United States from 2018 to 2021 and forecast to 2028. The report also details the latest information on vaccine price analysis, outlook and trends, as well as the regulatory framework for United States human vaccine market.
After conducting extensive research on historical and current growth metrics, the growth prospects of United States market for human vaccines are obtained with maximum precision.
This new 2022 market report provides a holistic analysis of all United States human vaccine market. The report offers the latest industry data on the real market situation and future prospects for United States’ human vaccine market.
The report also tracks and analyzes competitive developments, including collaboration, partnership agreements, distribution, exclusive and licensing agreements, new vaccine developments, and R&D activities in the market. The report also provides an in-depth analysis of changing market trends, drivers and restraining forces influencing market growth.
The report also analyzes detailed profiles of innovative and leading players with information on business overview, company vaccine portfolio, promising vaccines in clinical development and latest developments.
The report will serve as a source for a 360-degree analysis, completely integrating different models.
This Latest and Comprehensive Research Report on Human Vaccines Market in United States 2022 provides:
Comprehensive Research Methodology of Human Vaccines Market in the United States
Detailed and comprehensive market overview with key insights from analysts
Overview of market determinants driving the human vaccines market in the United States
To analyze historical market size growth of human vaccines market in United States from 2018 to 2021
Estimate and forecast the market size of Human Vaccines Market in United States from 2022 to 2028 and the growth rate till 2028
Detailed overview of the market value of the top 45 human vaccines used in the United States with a six-year forecast
An in-depth analysis of the market share of the top 45 vaccine brands and the annual growth rate
Provides comprehensive information on the latest price analysis, information and trends
Provides in-depth analysis of changing market trends, drivers, and restraints in the United States Human Vaccines Market
Extensive investigation of promising human vaccines in clinical development
Provides comprehensive information on the regulatory framework of the US Human Vaccines Market
Tracks competitive developments, approaches, recent industry developments, partnerships, collaboration agreements, distribution, exclusivity and license agreement
A comprehensive list of major companies along with analysis of their current vaccine portfolio, promising human vaccines in clinical development and current development
The report helps answer the following questions:
What is the current scenario of United States human vaccine market?
What is the total market size and forecast (till 2028) of United States human vaccine market?
What is the size United States human vaccine market?
At what CAGR is the U.S. human vaccines market expected to grow during the forecast period (2022-2028)?
What are the main human vaccines? What are their revenue potentials until 2028?
Which human vaccine brand provides the highest market share?
What is the regulatory framework for United States vaccine market?
What are the key factors that motivate United States human vaccine market?
What are the main challenges of United States human vaccine market?
What are the major chords and chords that occur in United States human vaccine market?
What are United States human vaccine price trends and analysis ?
What are the different human vaccines available in United States?
Who are the main market players? What are their current events, developments and scenarios?
How should the market evolve in the future?
Main topics covered:
2. United States Human Vaccines Market Size and Forecast (2018-2028)
3. United States Human Vaccine Brands Market Share and YoY Growth (%), 2018-2028
4. Key Market Growth Drivers and Challenges in United States Human Vaccines Market
4.1 Key Market Growth Drivers
4.2 Major Market Challenges
5. Top 45 Human Vaccines Market Value Analysis, Insights and Forecast in United States, 2018-2028
5.9 Engerix B
5.16 Quadrivalent FluMist
5.17 Prevnar 13
5.18 Gardasil 9
5.19 Fluzone Quadrivalent
5.21 Flucelvax Quadrivalent
5.22 Quadrivalent Afluria
5.27 Pneumovax 23
5.29 Laval Flu
5.38 Recombivax HB
5.46 Other vaccines
6. United States Human Vaccine Price Analysis, Outlook and Trends
7. Regulatory Framework of US Human Vaccines Market
8. Major Agreements and Agreements in Human Vaccines Market
8.1 Merger and acquisition
8.2 Collaboration offers
8.3 License Agreement
8.4 Exclusive Agreement
8.5 Distribution Agreement
8.6 Partnership Agreements
9. Leading companies in United States Human Vaccines Market
9.1 Sanofi Pasteur
9.1.1 Business Overview
9.1.2 Human Vaccines Portfolio
9.1.3 Promising human vaccines in clinical development
9.1.4 Recent Development
9.5 Seqirus (CSL Limited)
9.6 Astra Zeneca
9.7 Dynavax Technologies Company
9.8 Emergent BioSolutions Inc.
For more information on this report, visit https://www.researchandmarkets.com/r/7fdw9h
Research and Markets
For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716
Show original content:https://www.prnewswire.com/news-releases/united-states-human-vaccines-markets-2018-2021–forecast-to-2028-approvallaunches-of-the-new-vaccines–rising-focus- on-immunization-programs–increased-investment-and-government-support-301577149.html
SOURCE Research and Markets